Furthermore, tri-specific CAR T cells targeting HER2, IL13Ra2, and EphA2 provide an even more comprehensive coverage of TAs and have been shown to significantly prolong survival of mice bearing GBM patient derived xenografts (Bielamowicz et al., 2018). Here, ERBB2 is linked to glioblastoma.